Ocutrx Unveils ORLenz for Surgery Visualization Technology in ARWear Headset Print E-mail
By GLOBE NEWSWIRE   
Thursday, 10 October 2019 03:24

IRVINE, Calif., Oct. 10, 2019 (GLOBE NEWSWIRE)

IRVINE, Calif., Oct. 10, 2019 (GLOBE NEWSWIRE) -- Ocutrx Vision Technologies, LLC, a California-based technology startup developing a state-of-the-art augmented reality headset, is excited to reveal the company’s most significant technology milestone to date—a next generation AR headset technology for Surgery Visualization called the ORLenz™, a second medical device related to their flagship Oculenz™ ARWear™ headset for Macular Degeneration. A prototype of this technology is being formally introduced at the American Academy of Ophthalmology 2019 Conference in San Francisco this October during the dedicated Retina Subspecialty Day.

The ORLenz technology breakthrough will be available for surgeons and retinal specialists to utilize during procedures as an aid for delivering the most effective care possible. The ORLenz allows for a 120 degree field of view and a resolution of sixty pixels-per-degree —the highest resolution the human eye can discern (at 20/20). Ocutrx has developed its own 6DoF (6 degrees of freedom) platform for enhanced 2D and 3D “posing” of graphics and holograms from MRI’s, CT scans and other 2D/3D/4D medical imaging. The ORLenz also takes the direct feed from a digital microscope and portrays the surgery images to the surgeon in 2D or 3D. ORLenz’s MedTiles™ provide an overlay of vital surgery information on the 3D picture of the surgery. The ORLenz weighs about 250 grams and is wireless and tetherless, providing comfort and complete freedom of movement for the surgeon. It operates with Ocutrx’s WiDtrx wireless system which allows video transmission without wires at multi-gigabit speeds with the same or less latency than a hard-wired connection like HDMI.

“We have been looking forward to the debut of our new ORLenz for Surgery Visualization feature for quite some time now as we’ve painstakingly worked to fine tune the technology for optimal utility among surgeons across a wide variety of specialties and needs,” said Michael Freeman, CEO and CTO of Ocutrx. “Unveiling the prototype at the American Academy of Ophthalmology will provide an opportunity for hands-on demonstrations of the technology within a community of processionals who have been extremely vocal in expressing their interest in the value this tool will be able to offer them during delicate procedures.”

The ORLenz also has a MedTiles™ subsystem visual presentation, which is an overlay of vital information (text and graphs) in virtual display over the operating view. The MedTiles are virtually presented like windows or chyron generated information visible within the AR field-of-view. For Ophthalmologic surgery, included in the MedTiles is information like IOP (intraocular pressure), Cut Rate, and Flow Rate. The MedTiles also show which "Mode" a surgeon is in (Vitrectomy, Extrusion, Dense Tissue). This data is visible at the voice command of the surgeon and will run at the option of the surgeon at the bottom, side or top of his/her AR lens view. The MedTiles can also pose in a “horizon” view, where the surgeon can either dip his/her eyes below the virtual horizon to include this information as an overlay or raise his/her eyes above the horizon to only see the digital microscope view. The same works for either side viewing or top horizon. In this fashion, surgeons who dislike data distraction while conducting surgery can have the option of including the text and graph information at all times, or make a slight head or eye adjustment when needed to “see” the information when they choose.

“The ORLenz provides the surgeon with the immersive experience that he/she has been trained in and will allow the surgeon's full and undivided attention to rest on the patient, where it should be,” said Dr. Thomas A. Finley, MD, the Chairman of the Ocutrx International Advisory Board. “The ORLenz is AR, and there is a difference between immersion and isolation. With VR, you are cut-off from what else is happening in the surgery room, while with the ORLenz, the experience is immersive, yet, you can still easily stay connected with the other physicians, technicians and equipment in the surgery room.”
 
The ORLenz for Surgery Visualization technology introduced at AAO 2019 is a prototype, with the final version set to be available in Q2 2020 when the Oculenz ARWear headset becomes widely available for purchase. For more information about Ocutrx, the company’s patented eye tracking technology and the next generation Oculenz AR glasses, please visit www.oculenz.com.

About Ocutrx
With corporate headquarters in Irvine, California, and a research and development lab in the US Midwest, Ocutrx is a new breed of AR manufacturing company focusing on the best connected lightest weight AR headset housing the largest field-of-vision in the market. At a time when worldwide applications for easy-to-wear and easy-to-use AR solutions are being touted as the “next big thing after smartphones,” Ocutrx is creating impactful, revolutionary ARWear for mass use. To learn more about Ocutrx and its ground-breaking technology, please visit the company website at www.oculenz.com.

Media Contact:
Dave Feistel
Bastion Elevate (for Ocutrx Vision Technologies)
949-502-6200 ext. 224
[email protected]

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/c5a3ca17-78d6-46c6-9380-46a6e33e7ea4

Primary Logo

Ocutrz ORLenz Augmented Reality Wireless Surgery 3D Visualization Headset

Ocutrx Unveils ORLenz for Surgery Visualization Technology in ARWear Headset



"Featured Content" profiles are meant to provide awareness of these companies to investors in the small-cap and growth equity community and should not in any way come across as a recommendation to buy, sell or hold these securities. BiomedReports is not paid or compensated by newswires to disseminate or report news and developments about publicly traded companies, but may from time to time receive compensation for advertising, data, analytics and investor relation services from various entities and firms. Full disclosures should be read in the 'About Us Section'.

Add this page to your favorite Social Bookmarking websites
Digg! Reddit! Del.icio.us! Mixx! Google! Live! Facebook! Technorati! StumbleUpon! MySpace! Yahoo!
 

Newsletter